Ghisallo Capital Management »

Xilio Therapeutics shares owned by Ghisallo Capital Management

Quarter-by-quarter ownership of Xilio Therapeutics shares owned by Ghisallo Capital Management from 13F filings

Historical chart of Ghisallo Capital Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Ghisallo Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Ghisallo Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $116k 14k 8.41

More positions owned by Ghisallo Capital Management

Medline Com Cl A (MDLN)
Xpeng Ads (XPEV)
Hyuhi 05/04/31 Cvt Put Convertible Bond
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Ztoec 0.925 03/01/31 Cvt Put Convertible Bond
Microsoft Corporation (MSFT)
Wiwynn 04/01/31 Convertible Bond
Chpac 09/18/30 Cvt Put Convertible Bond
Globalfoundries Ordinary Shares (GFS)
Trane Technologies SHS (TT)
Johnson Controls Internation SHS (JCI)
Nipst 02/14/29 Cvt Convertible Bond
Oracle Corporation (ORCL)
Bltiv 02/05/33 Cvt Put Convertible Bond (JTGLF)

View all positions for Ghisallo Capital Management

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Frazier Life Sciences Management
Vanguard Capital Management
Merck & Co
Morgan Stanley
AJU IB Investment
Geode Capital Management
Vanguard Fiduciary Trust
GSA Capital Partners
Ghisallo Capital Management
UBS Group
Vanguard Global Advisers
Royal Bank of Canada
Key FInancial

View all funds holding Xilio Therapeutics